Peconic Bay Medical Center’s Cardiac Cath Unit Reaches Milestone
Peconic Bay Medical Center announced that its Robert Entenmann Catheterization Lab Unit at the Kanas Regional Heart Center successfully performed its 100th CardioMEMS implant.
CardioMEMS implants represent a breakthrough in the treatment of heart failure. The device, placed in a patient’s pulmonary artery, allows physicians to remotely track pressure changes that often occur before symptoms appear. This proactive monitoring enables doctors to adjust treatment earlier, preventing complications, reducing hospitalizations and helping patients manage their condition more effectively.
PBMC’s cardiac team also published the first known CardioMEMS implantation performed without contrast dye, using intravascular ultrasound instead. This approach benefits patients with kidney disease or dye allergies and highlights PBMC’s role in advancing the field.
“This achievement demonstrates the extraordinary skill of our clinical team and the high level of care we’re able to offer right here in Riverhead,” said Amy Loeb, Ed.D., MBA, RN, president of PBMC. “The CardioMEMS technology has transformed the way we can monitor and treat patients with heart failure, allowing them to live healthier, more independent lives. Reaching this 100th implant is a testament to the trust our patients place in PBMC and the dedication of our entire cardiac team.”
Patients often arrive at the emergency department with dangerously slow heartbeats, dizziness or loss of consciousness, requiring urgent intervention. Others are diagnosed in outpatient settings and scheduled for elective procedures.
“I’ve seen firsthand how CardioMEMS has transformed outcomes for patients living with heart failure,” said Andrew Persits, MD, director of interventional cardiology at PBMC. “What makes this milestone so meaningful is that it reflects the hundreds of lives improved through earlier intervention, reduced hospitalizations, and a better quality of life for our patients and their families.”